Manulife (Manufacturers Life Insurance)’s Xeris Biopharma Holdings XERS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $254K | Buy |
54,472
+3,562
| +7% | +$16.6K | ﹤0.01% | 2449 |
|
|
2025
Q1 | $279K | Sell |
50,910
-2,143
| -4% | -$11.8K | ﹤0.01% | 2365 |
|
|
2024
Q4 | $180K | Sell |
53,053
-3,090
| -6% | -$10.5K | ﹤0.01% | 2664 |
|
|
2024
Q3 | $160K | Sell |
56,143
-1,662
| -3% | -$4.74K | ﹤0.01% | 2743 |
|
|
2024
Q2 | $130K | Buy |
57,805
+5,291
| +10% | +$11.9K | ﹤0.01% | 2751 |
|
|
2024
Q1 | $116K | Sell |
52,514
-3,228
| -6% | -$7.13K | ﹤0.01% | 2745 |
|
|
2023
Q4 | $131K | Hold |
55,742
| – | – | ﹤0.01% | 2744 |
|
|
2023
Q3 | $104K | Hold |
55,742
| – | – | ﹤0.01% | 2795 |
|
|
2023
Q2 | $146K | Sell |
55,742
-546
| -1% | -$1.43K | ﹤0.01% | 2724 |
|
|
2023
Q1 | $91.7K | Hold |
56,288
| – | – | ﹤0.01% | 2764 |
|
|
2022
Q4 | $74.9K | Buy |
56,288
+1,161
| +2% | +$1.54K | ﹤0.01% | 2860 |
|
|
2022
Q3 | $86K | Sell |
55,127
-2,235
| -4% | -$3.49K | ﹤0.01% | 2850 |
|
|
2022
Q2 | $88.3K | Buy |
+57,362
| New | +$88.3K | ﹤0.01% | 2948 |
|
|
2021
Q2 | – | Sell |
-29,961
| Closed | -$135K | – | 3303 |
|
|
2021
Q1 | $135K | Buy |
29,961
+267
| +0.9% | +$1.2K | ﹤0.01% | 3008 |
|
|
2020
Q4 | $146K | Buy |
29,694
+2,862
| +11% | +$14.1K | ﹤0.01% | 2873 |
|
|
2020
Q3 | $159K | Buy |
+26,832
| New | +$159K | ﹤0.01% | 2654 |
|
|
2020
Q1 | – | Sell |
-17,351
| Closed | -$122K | – | 2910 |
|
|
2019
Q4 | $122K | Sell |
17,351
-1,145
| -6% | -$8.05K | ﹤0.01% | 2746 |
|
|
2019
Q3 | $178K | Buy |
18,496
+624
| +3% | +$6.01K | ﹤0.01% | 2647 |
|
|
2019
Q2 | $204K | Buy |
+17,872
| New | +$204K | ﹤0.01% | 2642 |
|